If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Advanced Materials Regulatory News (MGAM)

Share Price Information for Morgan Advanced Materials (MGAM)

Share Price is delayed by 15 minutes
Get Live Data
215.00    4.00 (1.90%)
Bid:
214.00
Ask:
215.00
Spread: 1.00 (0.467%)
Market Cap: £594.29m
MGAM Live PriceLast checked at - London Stock Exchange

Intraday Morgan Advanced Materials Share Chart

AGM Trading Update

17 Apr 2009 07:00

RNS Number : 7204Q
Morgan Crucible Co PLC
17 April 2009
 



AGM Trading Update

At today's AGM, Tim Stevenson, OBE, Morgan Crucible's Chairman, will provide the following update.

Group revenues for the first quarter were £255m compared to £178m in the equivalent period last year with strong first year performance from NP Aerospace and the businesses acquired from Carpenter. Excluding the impact of acquisitions, first quarter revenues were up c.11% year-on-year reflecting the benefits of favourable currency translation. In Q1 we have seen, as anticipated, a continuing downward trend in end-market demand meaning that, on a constant currency basis, organic revenues were down 9% compared to Q1 2008.

Of particular note in the period since our last reported results, is the award from the Ministry of Defence of a contract for the Tactical Support Vehicle (TSV) which we announced in early April. This will generate c.£30m of new revenues for NP Aerospace in the latter part of this year and the first half of 2010. 

The refinancing of the Group's banking facilities which mature in March 2010 has progressed well and we are now in the final stages of documentation for the new facility.

Going forward, the ongoing uncertainty in the global economy clearly makes it much more difficult to forecast demand accurately. However, to ensure that we are well prepared for any further deterioration in end market conditions, we are continuing to take decisive action to reduce our operating cost base. Group overall headcount at the end of Q1, excluding acquisitions, has been reduced by over 1,000 people (c.10%) worldwide from its levels of last summer and we stand ready to take further mitigating actions as required.

Our next announcement to shareholders will be our Interim Management Statement in mid May when we will update further on the Group's trading and prospects.

Enquiries:

The Morgan Crucible Company plc  01753 837000

Mark Robertshaw, Chief Executive

Kevin Dangerfield, Chief Financial Officer 

Finsbury Group 020 7251 3801

Mike Smith

Clare Strange

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMBRGDSGGBGGCL
Date   Source Headline
23rd Mar 202211:01 amRNSDirector/PDMR Shareholding
22nd Mar 20225:04 pmRNSDirector/PDMR Shareholding
4th Mar 20227:00 amRNSFull-year results
10th Jan 202211:30 amRNSHolding(s) in Company
15th Dec 202110:00 amRNSBlock listing Interim Review
7th Dec 202112:30 pmRNSHolding in Company
26th Nov 20213:32 pmRNSDirector/PDMR Shareholding
23rd Nov 20212:00 pmRNSDirector/PDMR Shareholding
5th Nov 20217:00 amRNSTrading Update
18th Oct 202112:21 pmRNSDirector/PDMR Shareholding
18th Oct 202112:20 pmRNSDirector/PDMR Shareholding
15th Oct 20217:00 amRNSCFO Appointment
14th Oct 20219:15 amRNSHolding in Company
11th Oct 202110:45 amRNSHolding in Company
28th Sep 20213:15 pmRNSDirector/PDMR Shareholding
17th Sep 20213:58 pmRNSDirector/PDMR Shareholding
16th Sep 202111:30 amRNSDirector/PDMR Shareholding
5th Aug 20211:39 pmRNSDirector/PDMR Shareholding
29th Jul 20217:00 amRNSHalf-year Results
15th Jun 20219:38 amRNSBlock Listing Interim Review
10th Jun 20219:18 amRNSDirector/PDMR Shareholding
27th May 20214:02 pmRNSDirector/PDMR Shareholding
25th May 20213:38 pmRNSDirector/PDMR Shareholding
11th May 202110:20 amRNSDirector/PDMR Shareholding
6th May 202111:54 amRNSResult of AGM
6th May 20217:00 amRNSDirectorate Change
6th May 20217:00 amRNSTrading Update
31st Mar 20212:08 pmRNSAnnual Financial Report
26th Mar 20219:54 amRNSHolding(s) in Company
24th Mar 202110:10 amRNSDirector/PDMR Shareholding
24th Mar 202110:08 amRNSDirector/PDMR Shareholding
24th Mar 202110:06 amRNSDirector/PDMR Shareholding
24th Mar 202110:05 amRNSDirector/PDMR Shareholding
4th Mar 202111:22 amRNSHolding(s) in Company
4th Mar 20217:00 amRNSFinal Results
15th Dec 202012:34 pmRNSBlock listing Interim Review
6th Nov 20207:00 amRNSQ3 Trading Update
16th Oct 20202:11 pmRNSDirector/PDMR Shareholding
6th Oct 20201:40 pmRNSDirector/PDMR Shareholding
28th Sep 20209:33 amRNSDirector Declaration
28th Sep 20209:19 amRNSDirector/PDMR Shareholding
1st Sep 20207:00 amRNSMorgan Advanced Materials announces divestment
10th Aug 202011:15 amRNSDirector/PDMR Shareholding
5th Aug 20205:16 pmRNSHolding(s) in Company
30th Jul 20207:00 amRNSHalf-Year Results
15th Jun 20204:09 pmRNSBlock listing Interim Review
15th Jun 20203:09 pmRNSHolding(s) in Company
5th Jun 20207:00 amRNSCOVID-19 update
20th May 20201:58 pmRNSDirector/PDMR Shareholding
7th May 20202:46 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.